Search Results - "Kacker, Seema"

Providers preferences towards greater patient health benefit is associated with higher quality of care by Kacker, Seema, Aung, Tin, Montagu, Dominic, Bishai, David

“…Standard theories of health provider behavior suggest that providers are motivated by both profit and an altruistic interest in patient health benefit…”
Get full text

Consider expenditure controls’ impacts on equity by Frick, Kevin D, Kacker, Seema, Ballreich, Jeromie

Get full text

Providing vouchers and value information for already free eye exams increases uptake among a low‐income minority population: A randomized trial by Kacker, Seema, Macis, Mario, Gajwani, Prateek, Friedman, David S.

“…We study whether vouchers without and with value information encourage attendance of already free follow‐up appointments among low‐income minority individuals…”
Get full text

Male Circumcision: A Globally Relevant but Under-Utilized Method for the Prevention of HIV and Other Sexually Transmitted Infections by Tobian, Aaron A.R, Kacker, Seema, Quinn, Thomas C

“…Randomized trials have demonstrated that male circumcision (MC) reduces heterosexual acquisition of HIV, herpes simplex virus type 2, human papillomavirus…”
Get full text

Financial Impact of Acute Kidney Injury After Cardiac Operations in the United States by Alshaikh, Husain N., Katz, Nevin M., Gani, Faiz, Nagarajan, Neeraja, Canner, Joseph K., Kacker, Seema, Najjar, Peter A., Higgins, Robert S., Schneider, Eric B.

“…Acute kidney injury (AKI) after major cardiac operations is a potentially avoidable complication associated with increased morbidity, death, and costly…”
Get full text

Financial analysis of large‐volume delayed sampling to reduce bacterial contamination of platelets by Kacker, Seema, Katz, Louis M., Ness, Paul M., Bloch, Evan M., Goel, Ruchika, Gehrie, Eric A., Lokhandwala, Parvez M., Tobian, Aaron A.R.

“…BACKGROUND Effective and financially viable mitigation approaches are needed to reduce bacterial contamination of platelets in the US. Expected costs of…”
Get full text

Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease by Gehrie, Eric A., Ness, Paul M., Bloch, Evan M., Kacker, Seema, Tobian, Aaron A. R.

“…BACKGROUND The pathogenesis of alloimmunization is not well understood, and initiatives that aim to reduce the incidence of alloimmunization are generally…”
Get full text

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype by Kacker, Seema, Vassallo, Ralph, Keller, Margaret A., Westhoff, Connie M., Frick, Kevin D., Sandler, S. Gerald, Tobian, Aaron A.R.

“…BACKGROUND Hemolytic disease of the fetus and newborn, classically caused by maternal–fetal incompatibility of the Rh blood group D antigen, can be prevented…”
Get full text

Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions by Kacker, Seema, Bloch, Evan M., Ness, Paul M., Gehrie, Eric A., Marshall, Christi E., Lokhandwala, Parvez M., Tobian, Aaron A.R.

“…BACKGROUND Bacterial contamination of platelets remains the leading infectious risk from blood transfusion. Pathogen reduction (PR), point‐of‐release testing…”
Get full text

The costs of transfusion: economic evaluations in transfusion medicine, Part 1 by Kacker, Seema, Frick, Kevin D., Tobian, Aaron A.R.

Get full text

Secondary bacterial culture of platelets to mitigate transfusion‐associated sepsis: A 3‐year analysis at a large academic institution by Fenwick, Alexander J., Gehrie, Eric A., Marshall, Christi E., Tobian, Aaron A. R., Shrestha, Ruchee, Kacker, Seema, Brunker, Patricia A. R., Shifflett, Lisa, Carroll, Karen C., Gozelanczyk, Donna, Goel, Ruchika, Ness, Paul M., Bloch, Evan M.

“…Background In 2019, the United States Food and Drug Administration published its final recommendations to mitigate bacterial contamination of platelets. We…”
Get full text

The costs of transfusion: economic evaluations in transfusion medicine, Part1 by Kacker, Seema, Frick, Kevin D, Tobian, Aaron A.R

Get full text

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients by Kacker, Seema, Ness, Paul M., Savage, William J., Frick, Kevin D., Shirey, R. Sue, King, Karen E., Tobian, Aaron A.R.

“…Background Sickle cell disease is associated with extensive health care utilization; estimated lifetime costs exceed $460,000 per patient. Approximately 30% of…”
Get full text

Data and interpretation: economic evaluations in transfusion medicine, P art 4 by Kacker, Seema, Frick, Kevin D., Tobian, Aaron A.R.

Get full text

Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda by Alfonso, Yira N, Bishai, David, Nantongo, Agnes, Kakembo, Rebecca, Kobusinge, Sarah, Kacker, Seema, Kigozi, Godfrey, Gray, Ronald

“…INTRODUCTION:Male circumcision (MC) is an effective intervention to reduce HIV acquisition in men in Africa. We conducted a cost analysis using longitudinal…”
Get full text

Constructing a model: economic evaluations in transfusion medicine, P art 3 by Kacker, Seema, Frick, Kevin D., Tobian, Aaron A.R.

Get full text

Constructing a model: economic evaluations in transfusion medicine, Part3 by Kacker, Seema, Frick, Kevin D, Tobian, Aaron AR

Get full text

Establishing a framework: economic evaluations in transfusion medicine, Part2 by Kacker, Seema, Frick, Kevin D, Tobian, Aaron A.R

Get full text

Establishing a framework: economic evaluations in transfusion medicine, P art 2 by Kacker, Seema, Frick, Kevin D., Tobian, Aaron A.R.

Get full text

The costs of transfusion: economic evaluations in transfusion medicine, P art 1 by Kacker, Seema, Frick, Kevin D., Tobian, Aaron A.R.

Get full text